1. Home
  2. CHMG vs EOLS Comparison

CHMG vs EOLS Comparison

Compare CHMG & EOLS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Chemung Financial Corp

CHMG

Chemung Financial Corp

HOLD

Current Price

$66.20

Market Cap

322.1M

Sector

Finance

ML Signal

HOLD

Logo Evolus Inc.

EOLS

Evolus Inc.

HOLD

Current Price

$6.37

Market Cap

284.3M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CHMG
EOLS
Founded
1833
2012
Country
United States
United States
Employees
N/A
N/A
Industry
Major Banks
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
322.1M
284.3M
IPO Year
1995
2018

Fundamental Metrics

Financial Performance
Metric
CHMG
EOLS
Price
$66.20
$6.37
Analyst Decision
Hold
Strong Buy
Analyst Count
2
5
Target Price
$57.00
$15.50
AVG Volume (30 Days)
10.0K
935.6K
Earning Date
04-17-2026
05-04-2026
Dividend Yield
2.04%
N/A
EPS Growth
N/A
1.23
EPS
1.91
N/A
Revenue
N/A
$297,176,000.00
Revenue This Year
$37.32
$13.27
Revenue Next Year
$9.13
$17.62
P/E Ratio
$35.86
N/A
Revenue Growth
N/A
11.61
52 Week Low
$45.55
$3.86
52 Week High
$70.83
$10.62

Technical Indicators

Market Signals
Indicator
CHMG
EOLS
Relative Strength Index (RSI) 57.42 75.57
Support Level $50.67 $5.88
Resistance Level $70.41 $6.40
Average True Range (ATR) 2.52 0.36
MACD -0.24 0.12
Stochastic Oscillator 25.30 82.70

Price Performance

Historical Comparison
CHMG
EOLS

About CHMG Chemung Financial Corp

Chemung Financial Corp is a bank holding firm. Through its subsidiaries, the company provides various financial services, including demand, savings, and time deposits, commercial, residential, and consumer loans, letters of credit, wealth management services, employee benefit plans, insurance products, mutual funds, and brokerage services, among others. The company's reportable segments are Core Banking, Wealth Management (WMG) services, and Holding company and CFS. Maximum revenue is generated from the Core Banking segment, which derives revenue by attracting deposits from the general public and using such funds to originate different types of loans, and to invest in securities. The Wealth Management (WMG) services segment provides trust and investment advisory services to clients.

About EOLS Evolus Inc.

Evolus Inc is a performance beauty company offering medical aesthetic products in the cash-pay aesthetic market. The company's commercially available products represent two product categories within medical aesthetics: injectable neurotoxins and injectable hyaluronic acid (HA) gels. Its commercial products are: Jeuveau, a proprietary 900-kilodalton, purified botulinum toxin type A formulation indicated for the temporary improvement in the appearance of moderate to severe frown lines, in adults; and Evolysse, a collection of injectable HA gels that utilizes first-generation cold technology. The line includes several products, including mid face, nasolabial folds, lips, and eyes. Geographically, the company currently has operations in the United States, Canada, Europe, and Australia.

Share on Social Networks: